GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Japan Tissue Engineering Co Ltd (TSE:7774) » Definitions » Market Cap

Japan Tissue Engineering Co (TSE:7774) Market Cap : 円17,584 Mil (As of Apr. 03, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Japan Tissue Engineering Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Japan Tissue Engineering Co's share price for the quarter that ended in Sep. 2024 was 円512. Japan Tissue Engineering Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 41 Mil. Therefore, Japan Tissue Engineering Co's market cap for the quarter that ended in Sep. 2024 was 円20,792 Mil.

Japan Tissue Engineering Co's quarterly market cap increased from Dec. 2023 (円20,549 Mil) to Mar. 2024 (円27,168 Mil) but then declined from Mar. 2024 (円27,168 Mil) to Sep. 2024 (円20,792 Mil).

Japan Tissue Engineering Co's annual market cap increased from Mar. 2022 (円20,833 Mil) to Mar. 2023 (円21,158 Mil) and increased from Mar. 2023 (円21,158 Mil) to Mar. 2024 (円27,168 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Japan Tissue Engineering Co's Enterprise Value for Today is 円13,318 Mil.


Japan Tissue Engineering Co Market Cap Historical Data

The historical data trend for Japan Tissue Engineering Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Japan Tissue Engineering Co Market Cap Chart

Japan Tissue Engineering Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23,391.36 30,660.55 20,832.93 21,157.81 27,168.09

Japan Tissue Engineering Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23,838.07 22,579.16 20,548.66 27,168.09 20,792.32

Competitive Comparison of Japan Tissue Engineering Co's Market Cap

For the Biotechnology subindustry, Japan Tissue Engineering Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Japan Tissue Engineering Co's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Japan Tissue Engineering Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Japan Tissue Engineering Co's Market Cap falls into.


;
;

Japan Tissue Engineering Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Japan Tissue Engineering Co's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )=Share Price (A: Mar. 2024 )*Shares Outstanding (EOP) (A: Mar. 2024 )
=円669*40.610
=円27,168

Japan Tissue Engineering Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=円512*40.610
=円20,792

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Japan Tissue Engineering Co  (TSE:7774) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Japan Tissue Engineering Co Market Cap Related Terms

Thank you for viewing the detailed overview of Japan Tissue Engineering Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Japan Tissue Engineering Co Business Description

Traded in Other Exchanges
N/A
Address
6-209-1 Miyakitadori, Gamagori, Aichi, JPN, 443-0022
Japan Tissue Engineering Co Ltd is a bio-venture enterprise. It is engaged in the development, manufacture, and sale of tissue-engineered medical products and related products. It operates through the Regenerative Medicine, and Research and Development support business segments. The main business goal is to use autologous culturing techniques to develop tissue-engineered medical products and then to manufacture and sell these same tissue-engineered products to medical institutions for medical treatment. The company's tissue-engineered medical products are used in autologous transplant cases, where living cells are taken from the actual patient himself, cultured and then transplanted back to that same patient.

Japan Tissue Engineering Co Headlines

No Headlines